Get the Stockscreener App
4.74
2.82%
0.13
After Hours:
4.74
Bioage Labs Inc stock is traded at $4.74, with a volume of 94,610.
It is up +2.82% in the last 24 hours and up +2.60% over the past month.
Bioage Labs Inc is a clinical-stage biopharmaceutical company developing therapeutic product candidates for metabolic diseases, such as obesity, by targeting the biology of human aging. Its focus is metabolic disease, one of the greatest healthcare challenges. The pipeline Products of the company are NLRP3 inhibitors, APJ against, and others.
See More
Previous Close:
$4.61
Open:
$4.64
24h Volume:
94,610
Relative Volume:
0.43
Market Cap:
$169.93M
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
+6.76%
1M Performance:
+2.60%
6M Performance:
+8.47%
1Y Performance:
+0.00%
1-Day Range:
$4.64
$4.81
1-Week Range:
$4.42
$4.81
52-Week Range:
$2.88
$26.62
Bioage Labs Inc Stock (BIOA) Company Profile
Name
Bioage Labs Inc
Sector
Phone
510-806-1445
Address
5885 HOLLIS STREET, EMERYVILLE
Compare BIOA with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
BIOA
Bioage Labs Inc
|
4.74 | 165.27M | 0 | 0 | 0 | 0.00 |
|
ZTS
Zoetis Inc
|
155.37 | 68.60B | 9.39B | 2.62B | 2.22B | 5.81 |
|
TAK
Takeda Pharmaceutical Co Adr
|
14.86 | 46.99B | 29.96B | 957.25M | 4.77B | 0.304 |
|
HLN
Haleon Plc Adr
|
9.71 | 43.17B | 14.26B | 1.98B | 2.47B | 0.4347 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
18.05 | 20.82B | 16.70B | -157.13M | 1.19B | -0.155 |
|
UTHR
United Therapeutics Corp
|
305.35 | 13.98B | 2.99B | 1.21B | 1.13B | 25.06 |
Bioage Labs Inc Stock (BIOA) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Feb-28-25 | Initiated | William Blair | Mkt Perform |
| Dec-10-24 | Downgrade | Morgan Stanley | Overweight → Underweight |
| Dec-09-24 | Downgrade | Citigroup | Buy → Neutral |
| Dec-09-24 | Downgrade | Jefferies | Buy → Hold |
| Oct-21-24 | Initiated | Citigroup | Buy |
| Oct-21-24 | Initiated | Jefferies | Buy |
| Oct-21-24 | Initiated | Morgan Stanley | Overweight |
View All
Bioage Labs Inc Stock (BIOA) Latest News
Tools to monitor BioAge Labs Inc. recovery probabilityMarket Performance Summary & Verified Technical Signals - Newser
Understanding BioAge Labs Inc.’s price movementIPO Watch & Reliable Intraday Trade Plans - Newser
Why BioAge Labs Inc. is moving today2025 Support & Resistance & Long-Term Safe Return Strategies - Newser
Comparing BioAge Labs Inc. in custom built stock radars2025 Breakouts & Breakdowns & Risk Managed Investment Entry Signals - Newser
What data driven models say about BioAge Labs Inc.’s futureMarket Activity Report & Long-Term Safe Investment Plans - Newser
Will BioAge Labs Inc. benefit from macro trends2025 Major Catalysts & Real-Time Stock Entry Alerts - Newser
Market reaction to BioAge Labs Inc.’s recent newsProduct Launch & Real-Time Chart Pattern Alerts - Newser
Earnings visualization tools for BioAge Labs Inc.Market Activity Report & AI Forecast for Swing Trade Picks - Newser
Will BioAge Labs Inc. stock go up soonPortfolio Performance Report & Consistent Profit Focused Trading Strategies - Newser
Key resistance and support levels for BioAge Labs Inc.Earnings Recap Summary & Growth Focused Stock Pick Reports - Newser
How to integrate BioAge Labs Inc. into portfolio analysis toolsInflation Watch & Target Return Focused Picks - Newser
How to read the order book for BioAge Labs Inc.July 2025 Update & Technical Pattern Alert System - Newser
What indicators show strength in BioAge Labs Inc.Earnings Overview Summary & AI Powered Market Entry Ideas - Newser
Full technical analysis of BioAge Labs Inc. stockOil Prices & AI Driven Price Forecasts - Newser
BioAge Labs Inc. recovery potential after sell off2025 Big Picture & Safe Capital Growth Trade Ideas - Newser
Tick level data insight on BioAge Labs Inc. volatilityTake Profit & Precise Swing Trade Entry Alerts - Newser
Will BioAge Labs Inc. bounce back from current supportWeekly Risk Summary & Real-Time Chart Pattern Alerts - Newser
What MACD and RSI say about BioAge Labs Inc.Take Profit & Fast Exit/Entry Strategy Plans - Newser
BioAge Labs Inc. stock trend forecastQuarterly Profit Review & Long-Term Growth Stock Strategies - Newser
BioAge Labs Inc. stock chart pattern explainedProfit Target & Daily Oversold Bounce Ideas - Newser
BIOA STOCK ALERT: Levi & Korsinsky Notifies BioAge Labs, Inc. Investors of an Ongoing Investigation - ACCESS Newswire
Using AI based signals to follow BioAge Labs Inc.Trend Reversal & Smart Allocation Stock Tips - Newser
BioAge Labs Inc. Sees Spike in Bullish Option Flow2025 Momentum Check & Safe Entry Zone Identification - 더경남뉴스
Is BioAge Labs Inc. trending in predictive chart models2025 Breakouts & Breakdowns & Risk Managed Investment Strategies - Newser
Published on: 2025-08-25 03:07:23 - Newser
BioAge Labs Inc. stock retracement – recovery analysisMarket Risk Summary & Safe Entry Trade Signal Reports - Newser
What is BioAge Labs Inc. s revenue forecastPortfolio Gains Summary & Weekly High Conviction Trade Ideas - sundaytimes.kr
Applying sector rotation models to BioAge Labs Inc.July 2025 PostEarnings & High Return Trade Opportunity Guides - Newser
Will BioAge Labs Inc. announce a stock splitJuly 2025 Spike Watch & Long-Term Growth Plans - theviewers.co.kr
Pullback Watch: What hedge funds are buying BioAge Labs Inc.July 2025 Institutional & Weekly High Conviction Trade Ideas - theviewers.co.kr
MACD Signals Flash Warning for BioAge Labs Inc. StockJuly 2025 Earnings & Advanced Swing Trade Entry Alerts - 더경남뉴스
How do insiders feel about BioAge Labs Inc.2025 Major Catalysts & Precise Buy Zone Identification - sundaytimes.kr
BioAge Labs Inc. Volume Confirms Breakout — Analysts Bullish2025 Winners & Losers & Free Verified High Yield Trade Plans - 더경남뉴스
Sector Leaders Rotate Capital Into BioAge Labs Inc.Trade Performance Summary & Real-Time Buy Signal Alerts - newsyoung.net
Is BioAge Labs Inc. Forming a Bottom Pattern2025 Valuation Update & Free Daily Entry Point Trade Alerts - kangso.co.kr
BioAge Labs to Present at Upcoming Investor Conferences - The Manila Times
Clinical-Stage Biotech BioAge Labs Announces Key Presentations at Citi and Morgan Stanley Healthcare Events - Stock Titan
Tools to assess BioAge Labs Inc.’s risk profilePortfolio Update Report & Verified Momentum Stock Alerts - Newser
How to use a screener to detect BioAge Labs Inc. breakoutsWeekly Profit Recap & Weekly Breakout Watchlists - Newser
BioAge Labs announces first participant dosed in Phase 1 trial of BGE-102 - MSN
BioAge commences dosing in trial of obesity treatment candidate BGE-102 - Yahoo Finance
Is BioAge Labs Inc. stock good for income investorsJuly 2025 Setups & Safe Investment Capital Preservation Plans - 선데이타임즈
What technical models suggest about BioAge Labs Inc.’s comebackJuly 2025 Trade Ideas & Fast Moving Stock Trade Plans - Newser
Bioage Labs Inc Stock (BIOA) Financials Data
There is no financial data for Bioage Labs Inc (BIOA). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
0.93%
1.25%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):